Effects of Renal Impairment on the Pharmacokinetics and Safety of Udenafil-Reference-Cited by-同舟云学术

Effects of Renal Impairment on the Pharmacokinetics and Safety of Udenafil

Published:2018-03-14 Issue:7 Volume:58 Page:905-912
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Cho Yong-Soon¹,Noh Yook-Hwan²^ORCID,Lim Hyeong-Seok¹,Cho Sang-Heon³,Ghim Jong-Lyul⁴,Choe Sangmin⁵,Kim Soon-Bae⁶,Park Jung-Sik⁶,Lee Sang-Koo⁶,Yang Won-Seok⁶,Chang Jai-Won⁶,Bahng Mi-Young⁷,Bae Kyun-Seop¹

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics; University of Ulsan; Seoul Republic of Korea

2. Hallym Institute for Clinical Medicine; Hallym University Medical Center; Anyang Gyeonggi-do Republic of Korea

3. Department of Clinical Pharmacology and Therapeutics; Inha University; Incheon Republic of Korea

4. Department of Clinical Pharmacology; Korea University Anam Hospital; Seoul Republic of Korea

5. Clinical Trials Center; Pusan National University Hospital; Busan Republic of Korea

6. Department of Internal Medicine; University of Ulsan; Seoul South Korea

7. Department of Product Development; Dong-A ST Seoul Republic of Korea

Funder

Dong-A ST Company

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. Erectile dysfunction;Lue;N Engl J Med,2000

2. Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects;Kim;Br J Clin Pharmacol,2008

3. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction;Paick;J Sex Med,2008

4. Simultaneous determination of udenafil and its active metabolite, DA-8164, in human plasma and urine using ultra-performance liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study;Bae;Biomed Chromatogr BMC,2008

5. Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic;Ji;Xenobiotica,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions;Expert Opinion on Investigational Drugs;2024-08-11

2. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives;Journal of Medicinal Chemistry;2020-12-14

3. Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor;Acta Pharmacologica Sinica;2020-06-24

4. Stimulating effects of vardenafil, tadalafil, and udenafil on vascular endothelial growth factor, angiogenesis, vitamin D3, bone morphogenic proteins in ovariectomized rats;Archives of Physiology and Biochemistry;2020-04-21

5. Role of Clinical Pharmacokinetics Studies in Contemporary Oncology Drug Development;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2020